HCMT
TECH icon

Highland Capital Management (Tennessee)’s Bio-Techne TECH Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-37,116
Closed -$1.94M – 324
2019
Q2 		$1.94M Buy
+37,116
New +$1.87M 0.14% 161

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Highland Capital Management (Tennessee)'s TECH Position: Q3 2019 in Review

Highland Capital Management (Tennessee) sold out of Bio-Techne (TECH) in Q3 2019, closing a stake of 37,116 shares — an estimated $1.94M sold.

Highland Capital Management (Tennessee) first reported a position in TECH in Q2 2019 and held it in 1 quarter. The position peaked at $1.94M in Q2 2019. 341 funds tracked by Wall St. Rank hold TECH as of Q3 2019.

  • Highland Capital Management (Tennessee) reported no remaining Bio-Techne position as of Q3 2019 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 37,116 Bio-Techne shares in Q3 2019, an estimated $1.94M.
  • Highland Capital Management (Tennessee) first reported a position in Bio-Techne in Q2 2019 and held it in 1 quarter.
  • Highland Capital Management (Tennessee)'s Bio-Techne position peaked at $1.94M in Q2 2019.
  • 341 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2019.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q3 2019, filed 20 Nov 2019.